More Chimeric Therapeutics Limited news
Chimeric Therapeutics LimitedASX: CHM

$5 million Placement to progress CHM CDH17 trial

Oct 21, 2024 at 5:09 AM UTC

Chimeric Therapeutics Ltd has released a press release.

View Attachment